Profound Medical raises Q3 2026 revenue outlook above estimates

Go back to Profound Medical raises Q3 2026 revenue outlook above estimates

Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue

October 7, 2026 4:15 PM EDT

Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47%

TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced preliminary unaudited revenues for the third quarter ended September 30, 2026. Unless specified otherwise, all amounts in this press release are expressed in... More